In 2016, dementia became the leading cause of death for Australian women (Australian Bureau of Statistics (ABS). Causes of death, Australia, 2016. ABS cat. no. 3303.0. Canberra: ABS, 2017).
In 2018, 436,366 Australians were living with dementia (Dementia Australia. Dementia Prevalence Data 2018-2058, commissioned research undertaken by NATSEM, University of Canberra, 2018).
The Hart Clinic in Sydney offers a personalised and comprehensive program based on the protocol formulated by Professor Dale Bredesen. Dr Hart is an accredited RECODE practitioner, having trained with Professor Bredesen in California. We treat cognitive decline, early Alzheimer's Disease, traumatic brain injury and other neurodegenerative disorders as well as preventing these diseases. Whether you or a loved one has noticed changes in memory or mood, or you want to reduce your risk of dementia and optimise your brain function, getting a brain health check and a personalised program could literally change you or your loved one's life.
Research shows that there are significant benefits of many non-pharmaceutical approaches to reduce the risk of Alzheimer’s, or even to reverse the effects of early-stage disease. Those with mild cognitive impairment are most likely to benefit from these approaches.
In 2014 Professor Dale Bredesen, a Professor in Neurology at the University of California Los Angeles and a neuroscientist at The Buck Institute for Research on Aging in California, published a paper documenting the reversal of early Alzheimer's and mild cognitive impairment. Since then he has published 3 additional papers describing the science and reporting successes with reversing early Alzheimer's. Like Professor Bredesen, we are hopeful that his information, research, and support will contribute towards reducing the global burden of dementia.
WHO DO WE TREAT?
Anyone wanting to prevent cognitive decline and/or improve their performance! You might be an executive who has noticed changes in mental function, an athlete or a student wanting that extra edge. Neurocognitive decline can effect anyone, so get on the front foot and PREVENT IT.
Subjective cognitive impairment (SCI)
You know there is something wrong but the tests are within the normal range.
Mild cognitive impairment (MCI)
Your tests are slightly abnormal and your symptoms are beginning to impact your day to day functioning.
EARLY Alzheimer’s Disease
You have recently had a diagnosis of Alzheimer's Disease, and are in the early stages of the disease.
Traumatic brain injury
You have had an acute or repetitive trauma directly to the skull or indirectly via the body. This can be with or without loss of consciousness.
Optimal Brain Performance and Prevention
You want to reduce your risk of dementia and optimise your cognition and memory for peak physical and mental performance.
Unfortunately there are no medications that have yet been developed to cure or prevent Alzheimer's. The monotheraputic drug approach has largely been unsuccessful in treating Alzheimer's and other neurodegeneraltive diseases.
Between 2002 and 2012 there were 244 drug trials for Alzheimers of which 243 failed. Some of these drugs actually made the disease worse, and the best one showed minimal success.
The main drug used in Alzheimers - Aricept (donazepil) - benefits are mild and often unnoticed by patients and family members. No scientific evidence for effectiveness.
Second most common drug Namenda (memantine) - no effect in early AD, and accelerates disease in mild to moderate AD in some studies.
Alzheimer's is a complex multifactorial disease that requires an approach that addresses the many underlying causes, the combination of which are unique to each individual.
Our BRAIN HEALTH PROGRAM
Our protocol is based on the work of Professor Dale Bredesen. For more information about treatment please call or email our clinic as testing and treatment is highly personalised.
We undertake detailed functional, physiological, blood, stool, urine and medical imaging investigations to objectively quantify your state of brain health and the factors contributing to it. This involves investigating your whole health including metabolic, cardiovascular, gut health, chronic infections and many lifestyle factors.
Your results are analysed to determine the factors that need to be addressed to reduce further neurocognitive decline (see a detailed explanation of these here).
An individualised treatment program is then formulated to address your biology and lifestyle factors. In most of the published case studies, depending on the extent of the neurocognitive decline, and the ability of the patient to make the appropriate changes that are necessary, results are seen in 6 to 12 months, sometimes sooner. Obviously the more severe the disease, the less recovery that is possible.
One of the biggest concerns for ageing Australians is the loss of mental faculties.
Dementia is the second leading cause of death and the single greatest cause of disability in Australia. (Australian Bureau of Statistics (2015) Causes of Death, Australia, 2013: Cat no. 3303.0).
If you are the child of a parent with dementia you have had an early warning message, and can take action for yourself.
Women make up the greater proportion of patients and carers.
Family members often notice changes three years before a formal diagnosis is made (the earlier treatment is commenced, the better the results).
There is no medication that reverses the progress of Alzheimer's.
Type 2 diabetes doubles the risk of Alzheimers (and there are many other risk factors).